1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Global Inferior Vena Cava (IVC) Filters - Market Growth Analysis, 2009-2015

Global Market Watch:
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.
Global IVC filters market forecasts to reach at US$0.55 billion by 2015 at a CAGR of 11.3% during the analysis period 2009-2015. The North American segment accounts for nearly 40% of the global value while Europe claims more than 25% of the market. Asia-Pacific is the fastest growing region with a CAGR of 13% driving a market value of US$0.14 billion by 2015. On a global scale, projections for retrievable IVC filter segment indicate a close to 60% by 2015 leaving the rest of the market to permanent type.

Report Focus:
The report ‘Global Inferior Vena Cava (IVC) Filters - Market Growth Analysis, 2009-2015’ reviews the latest trends in IVC filters with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.

The report primarily focuses on:
• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand Of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies
The report covers the market analysis by product types.
The subdivisions are as:

- By Product
1. Retrievable Filters
2. Permanent IVC Filters

The period considered for the study analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 700 leading market players are identified and 95 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 83 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry.

Table Of Contents

Global Inferior Vena Cava (IVC) Filters - Market Growth Analysis, 2009-2015
I. REPORT FOCUS

A. INTRODUCTION
BRADYCARDIA
SENSOR EXPERTISE WILL URGE DEVELOPMENT IN PACEMAKER MARKET
PROGRESS OF RATE-RESPONSIVE PACEMAKERS WITH SEVERAL SENSORS - INDUSTRY OVERVIEW

TACHYCARDIA

CARDIOPULMONARY (CPB)
A DEVICE IDENTIFIES PATIENTS RISK

B. INFERIOR VENA CAVA (IVC) FILTERS
IVC FILTER BRANDS
GREENFIELD FILTER
A. RETRIEVABLE FILTERS
B. PERMANENT IVC FILTERS

C. A REVIEW ON CARDIAC DISEASES
CARDIOVASCULAR DISEASES
CARDIOVASCULAR DISEASE STATISTICS
MORTALITY FROM MAJOR CARDIOVASCULAR DISEASES: UNITED STATES

RHEUMATIC HEART DISEASE
RHEUMATIC HEART DISEASE STATISTICS

CORONARY ARTERY DISEASE (CAD) OR CORONARY HEART DISEASE (CHD)
CORONARY ARTERY DISEASE (CAD) STATISTICS

CEREBROVASCULAR DISEASE - STROKE

PERIPHERAL VASCULAR DISEASE (PVD)
PERIPHERAL VASCULAR DISEASE (PVD) - EPIDEMIOLOGY
PERIPHERAL VASCULAR DISEASE (PVD) - SCREENING

VALVULAR HEART DISEASE
DIAGNOSIS

HYPERTENSIVE HEART DISEASE

CONGESTIVE HEART FAILURE (CHF)
INCIDENCE AND PREVALENCE
FACTS ABOUT CHF

ARTRIAL FIBRILLATION (AF)
ARTRIAL FIBRILLATION (AF) - EPIDEMIOLOGY

ISCHAEMIC HEART DISEASE

INFLAMMATORY HEART DISEASE

HEART ATTACK AND ANGINA STATISTICS
STROKE STATISTICS

D. INFERIOR VENA CAVA (IVC) FILTERS - TYPES - MARKET BRIEFING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

II. MARKET ANALYSIS
INFERIOR VENA CAVA (IVC) FILTERS - INDUSTRY SNAPSHOT

A. INFERIOR VENA CAVA (IVC) FILTERS - SEGMENTATION
INFERIOR VENA CAVA (IVC) FILTERS - GLOBAL
INFERIOR VENA CAVA (IVC) FILTERS - BY GEOGRAPHY

INFERIOR VENA CAVA (IVC) FILTERS- BY COUNTRY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

GLOBAL INFERIOR VENA CAVA (IVC) FILTERS - BY TYPE
INFERIOR VENA CAVA (IVC) FILTERS - TYPES - GEOGRAPHIC REGION
RETRIEVABLE FILTERS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

PERMANENT IVC FILTERS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

B. GROWTH RATE ANALYSIS
GLOBAL INFERIOR VENA CAVA (IVC) FILTERS MARKET GROWTH RATES

INFERIOR VENA CAVA (IVC) FILTERS MARKET - TYPES
GLOBAL INFERIOR VENA CAVA (IVC) FILTERS TYPES - GROWTH RATES

C. INVESTMENT FOCUS

III. GLOBAL CARDIAC MEDICAL DEVICES INDUSTRY OVERVIEW
FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS
IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS

A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
1. CARDIAC RHYTHM MANAGEMENT DEVICES
CRM IN EUROPE

CARDIAC DEFIBRILLATORS
RAPID GROWTH IN DEFIBRILLATOR SALES

CARDIAC PACEMAKER DEVICES
STATISTICS ON PACEMAKERS AND IMPLANTABLE CARDIAC DEVICES PRESENTED AT EUROPACE 2009
THE DATA COLLECTION WORK

CARDIAC RESYNCHRONIZATION THERAPY (CRT)
2. CARDIAC MONITORING AND DIAGNOSTIC DEVICES
THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE
HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW

3. INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS
EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION

CARDIAC CATHETERS
COMPETITIVE ANALYSIS

INTRAVASCULAR ULTRASOUND CATHETERS (IVUS)
GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS
ARTERIOTOMY CLOSURE DEVICES

4. PERIPHERAL VASCULAR DEVICES
EMBOLIC PROTECTION DEVICES (EPD)

INFERIOR VENA CAVA (IVC) FILTERS
CONCLUSION

PERIPHERAL GUIDEWIRES

AV ACCESS THROMBECTOMY DEVICES

5. CARDIAC PROSTHETIC DEVICES

6. ELECTROPHYSIOLOGY CATHETERS (EP)
GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH

EP MAPPING
NEW AF ABLATION DEVICES SEEK APPROVAL

ATRIAL FIBRILLATION (AF)

SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
MARKET CHALLENGES

B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
SIZE AND WEIGHT
POWER EFFICIENCY
PERFORMANCE SPECIFICATIONS
RISK MITIGATION AND RELIABILITY

C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
IMPACT OF CVD IN EUROPE
IMPACT ON NEW YORK STATE
ECONOMIC IMPACT OF CVD IN NYS
HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
IMPACT OF CVD ON ECONOMIC STABILITY

ECONOMIC COST OF CARDIOVASCULAR DISEASES
COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030
CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE

D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND

E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES SEGMENT
CARDIOVASCULAR MEDICAL DEVICE APPROVALS - IN DETAIL

F. INDUSTRY ACTIVITIES
MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/ETC……
EDWARDS LIFESCIENCES' REDESIGNED TRANSCATHETER HEART VALVE SAPIEN XT SHOWS IMPROVEMENTS
PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
PHILIPS LAUNCHES THREE NEW IMAGING SYSTEMS
IRHYTHM PUBLISHES ZIO® PATCH STUDY RESULTS DEMONSTRATING SUPERIOR ABILITY TO DETECT AF
SUPERSONIC IMAGINE UNVEILS AIXPLORER® ERGONOMICS AND ULTRAFAST™ PLATFORM
ROYAL PHILIPS HEALTHCARE AND INFRAREDX LAUNCH SOLUTION FOR SEAMLESS INTEGRATION OF TVC IMAGING SYSTEM WITH PHILIPS' ALLURA XPER SYSTEMS
MERIT MEDICAL RECEIVES CE MARKING FOR EMBOSPHERE(R)
CARDIONET ANNOUNCES PARTNERSHIP WITH IMEC AND HOLST CENTRE FOR NEXT GENERATION CARDIAC MONITORING PRODUCTS
INVENTIV HEALTH CLINICAL NAMED “CLINICAL COMPANY OF THE YEAR”
NANO-MATERIALS VITAL IN DEVELOPING TOUGHER ARTIFICIAL HEARTS
VOLCANO INTRODUCES LATEST IPAD TEACHING SOLUTION FOR ITS NEWLY-RELEASED VISIONS® PV .035 DIGITAL IVUS CATHETER
CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
WELCH ALLYN TO DISTRIBUTE EARLYSENSE PATIENT MONITORING SYSTEM IN US
JLL PARTNERS SIGNS AGREEMENTS TO ACQUIRE BIOCLINICA AND CORELAB PARTNERS
SANOFI UNVEILS PATH BREAKING TECHNOLOGY FOR CARDIOVASCULAR AND VASCULAR SURGERY PROCEDURES
MEDTRONIC FINISHES SE STENT ACQUIRES CE MARK FOR APPLICATION IN LOWER EXTREMITIES
ANGIOSCORE PRESENTS NEW SIZE OF ANGIOSCULPT PTA SCORING BALLOON CATHETERS
ON-X LIFE TECH INTRODUCES LATEST HEART VALVE REPLACEMENT DEVICE
BIOSENSORS ACQUIRES CE MARK SANCTION FOR BIO-FREEDOMâ„¢
MEDTRONIC FINISHES PATIENT ENROLLMENT FOR IN.PACT ADMIRAL DRUG-ELUTING BALLOON STUDY
BIOTRONIK BEGINS MATRIX STUDY FOR IMPROVED DETECTION AND MANAGEMENT OF ATRIAL FIBRILLATION
DEFIBETCH'S LIFELINE PRO AND LIFELINE ECG AEDS ACHIEVE FDA CLEARANCE
ABBOTT POSTS LAST-QUARTER AND FULL-YEAR 2012 OUTCOMES
ST JUDE MEDICAL OBTAINS CE MARK FOR AMPLATZER AMULET LEFT ATRIAL APPENDAGE OCCLUDER
NCONTACT GETS FDA CLEARANCE FOR EPI-SENSE CARDIAC ABLATION DEVICE WITH EMBEDDED SENSORS
PHILIPS PRESENTS ADVANCED EP NAVIGATOR AT BOSTON AF SYMPOSIUM
ST JUDE MEDICAL GETS CE MARK APPROVAL FOR VIEWFLEX XTRA ICE CATHETER
BOSTON SCIENTIFIC ZERO AF TRIAL TREATS FIRST PATIENT TO EVALUATE BLAZER OPEN-IRRIGATED CATHETERS
DEFIBTECH'S LIFELINE AUTO AUTOMATIC EXTERNAL DEFIBRILLATOR CLEARED FOR SALE IN THE US
NOVATION OPTS FOR NIHON KOHDEN PERMANENT VITAL SIGNS MONITORING SYSTEM
ST. JUDE'S REMOTE MONITORING SYSTEM ACQUIRES FDA SANCTION
ST. JUDE POSTS PRELIM 4Q RESULTS
AMBIO DISPLAYS REMOTE HEALTH MONITORING SYSTEM
MICROSEMI'S LATEST RF MODULES SPEED TIME-TO-MARKET FOR IMPLANTABLE MEDICAL DEVICE DESIGNERS
ABBOTT'S ABSORB BVS EVALUATED FOR TREATMENT OF CAD AT CHRIST HOSPITAL
ABBOTT INITIATES ABSORB III CLINICAL TRIAL IN THE UNITED STATES
CARDIAC SCIENCE TO DELIVER POWER-HEART G3 AEDS TO CHICAGO METRA
ABBOTT RECEIVES FDA APPROVAL FOR NEXT-GENERATION XIENCE XPEDITIONâ„¢ DRUG ELUTING STENT SYSTEM
FDA 515I RECLASSIFICATION PANEL ENDORSES CLASS III STATUS FOR TEMPORARY VENTRICULAR SUPPORT DEVICES IN THE NON-ROLLER TYPE CARDIOPULMONARY BYPASS BLOOD PUMPS CATEGORY
BIOTRONIK HOME MONITORING® REDUCES INAPPROPRIATE ICD SHOCKS BY 52% - ECOST TRIAL RESULTS
CARDIACASSIST BEGS FDA'S APPROVAL FOR TANDEMHEART CLINICAL STUDY
BOSTON SCIENTIFIC STARTS CLINICAL TRIAL OF INGEVITYâ„¢ PACING LEADS
CARDIOMEMS TO CREATE WIRELESS SENSORS BASED PATIENT-MONITORING DEVICE FOR CARDIAC DISEASES
THORATEC REPORTS APPROVAL FOR HEARTMATE II® IN JAPAN
GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
SORIN GROUP ANNOUNCES FIRST PARADYMâ„¢ RF IMPLANT AND SMARTVIEWâ„¢ REMOTE MONITORING IN NORTH AMERICA
EDWARDS LIFESCIENCES FORECASTS STRONG GROWTH IN SALES AND EARNINGS IN 2013
SORIN GROUP INTRODUCES FIRST PARADYMâ„¢ RF IMPLANT AND PRIMARY SMARTVIEWâ„¢ REMOTE MONITORING STIMULATED PATIENT IN NORTH AMERICA
SORIN GROUP RECEIVES PMDA APPROVAL AND ANNOUNCES COMMERCIAL LAUNCH OF THE MITROFLOW® AORTIC PERICARDIAL HEART VALVE IN JAPAN
SORIN GROUP RECEIVES PMDA APPROVAL FOR THE MITROFLOW®AORTIC PERICARDIAL HEART VALVE IN JAPAN; COMMERCIAL LAUNCH ANNOUNCED.
VOLCANO CORPORATION INKS AGREEMENT TO ACQUIRE CRUX BIOMEDICAL
IMPEDANCE CARDIOGRAPHY SET TO REPLACE HUT FOR VASOVAGAL SYNCOPE DIAGNOSIS
EDWARDS LIFESCIENCES RECEIVES CHINA'S SFDA APPROVAL FOR PERIMOUNT MITRAL HEART VALVE
GE HEALTHCARE DEVELOPS SOLUTIONS TO ENHANCE THE CT APPLICATIONS
UNIVERSITY OF WISCONSIN AND GE HEALTHCARE GET INTO AN AGREEMENT FOR PROTOCOLS TO ENHANCE DISEASE DIAGNOSIS
BIOTRONIK STUDY TO ASSESS INNOVATIVE INTRACARDIAC IMPEDANCE SENSING TECHNOLOGY FOR CRT OPTIMIZATION
MERIT MEDICAL SIGNS AGREEMENT TO ACQUIRE THOMAS MEDICAL PRODUCTS FROM GE HEALTHCARE
AGFA HEALTHCARE SIGNS DISTRIBUTION AGREEMENT WITH GULF MEDICAL
ST. JUDE MEDICAL ANNOUNCES FIRST PORTICO TRANSCATHETER AORTIC HEART VALVE IMPLANTATION USING TRANSAPICAL DELIVERY SYSTEM
SORIN GROUP ADVANCES IN HIGHLIFE, A EXPANSION-LEVEL COMPANY AIMED FOR PERCUTANEOUS MITRAL VALVE TRANSPLANT SYSTEM
VOLCANO SIGNS DEFINITIVE AGREEMENT TO ACQUIRE SYNC-RX LTD
ECARDIO UNVEILS INSTRUCTIONAL PATIENT VIDEO SERIES TO ENHANCE MONITORING EXPERIENCE
HEARTWARE ACHIEVES FDA APPROVAL FOR HEARTWARE® VENTRICULAR ASSIST SYSTEM AS A BRIDGE TO HEART TRANSPLANTATION FOR PATIENTS WITH END-STAGE HEART FAILURE
ST. JUDE MEDICAL ACHIEVES CE MARK APPROVAL FOR PORTICO TRANSCATHETER AORTIC HEART VALVE
BIOTRONIK'S NEW EVIA HF-T CRT PACEMAKER IMPLANTED IN THE FIRST 34 US PATIENTS
COOK MEDICAL BEGS FDA'S APPROVAL FOR ZILVER PTX
COOK MEDICAL SIGNS CONTRACT WITH NOVATION FOR PERIPHERAL VASCULAR PRODUCTS
COOK MEDICAL BEGS FDA'S MARKETING APPROVAL FOR ZILVER® PTX®
BIOTRONIK UNVEILS 3FLOW ASPIRATION CATHETER FOR IMPROVED THROMBUS ASPIRATION.
SORIN GROUP ACQUIRES NEUROTECH.
HEARTWARE RELEASES THIRD QUARTER 2012 RESULTS
CAL FIRE AND CCGA DEPLOY ZOLL'S NEW VERSION OF POCKETCPR
SORIN GROUP DECLARES U.S INTRODUCTION OF NEW HEART DEVICE FOR SIMULTANEOUS IMPLANTATION OF AN AORTIC TISSUE VALVE AND ASCENDING AORTA
ST. JUDE MEDICAL UNVEILS ITS MEDIGUIDE TECHNOLOGY
LIDCO LAUNCHES LIDCORAPID V2 AT ESICM AND ASA
NIHON KOHDEN TO PURCHASE DEFIBTECH (U.S. COMPANY)
ASAHI KASEI ZOLL A JAPANESE SUBSIDIARY ESTABLISHED BY ZOLL® MEDICAL CORPORATION
C. R. BARD ACQUIRES NEOMEND
K-TUBE TECHNOLOGIES JOINS HAND WITH MER-EUROPE AND MEDICAL METALS
STENTYS RECEIVES IDE APPROVAL FROM THE FDA TO CONDUCT THE FIRST U.S. CLINICAL TRIAL WITH SELF-APPOSING® STENT
RE -REGISTRATION OF MUSTANG® CORONARY STENT SYSTEM SUCCESSFULLY BY SFDA.
EDWARDS LIFESCIENCES' TRANSCATHETER VALVE RECEIVES EXPANDED INDICATION FROM FDA
ST. JUDE MEDICAL REVIEW
ENDOLOGIX FINALIZES PATENT LITIGATION WITH COOK MEDICAL
CATHRX SIGNS MANUFACTURE AND SUPPLY AGREEMENT WITH GMMI SDN BHD
ZOLL AND GS GMBH CREATE LICENSING AGREEMENT TO INCORPORATE REAL CPR HELP IN CORPULS DEFIBRILLATORS
U.S. PATENT AND TRADEMARK OFFICE HAVE AWARDED POSITRON A PATENT FOR SOLID STATE SENSORS.
INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
BIOTRONIK LAUNCHES IMPLANTABLE BIOMONITOR®, WHICH HAS THE HIGHEST PRECISION IN MONITORING ARRHYTHMIAS
EDWARDS LIFESCIENCES ACQUIRES BMEYE
VOLCANO LAUNCHES PRIMEWIRE PRESTIGE® PLUS PRESSURE GUIDE WIRE WITH ACUSENSE™ TECHNOLOGY
COOK MEDICAL GAINS HEALTH CANADA APPROVAL FOR ITS ZILVER VENA STENT
VOLCANO RECEIVES CE MARK AND 510(K) CLEARANCE FOR NEW VISIONS® PV .035 DIGITAL IVUS CATHETER
BOSTON SCIENTIFIC LAUNCHES PROMUS ELEMENTâ„¢ STENT
TERUMO BROADENS LICENSING AGREEMENT WITH BIOSENSORS TO SELL NOBORI® DES SYSTEM INCORPORATING BIOMATRIX™ TECHNOLOGY
MALLINCKRODT ACQUIRES CNS THERAPEUTICS
CARDIAC SCIENCE LAUNCHES WEARABLE BURDICK® 4250 HOLTER RECORDER
COVIDIEN LAUNCHES SONICISIONâ„¢ CORDLESS ULTRASONIC DISSECTION DEVICE AND IDRIVEâ„¢ ULTRA POWERED STAPLING SYSTEM AT ACS
ESTECH RELEASED THE COBRA FUSIONâ„¢ SYSTEM FOR CARDIAC ABLATION
BIOTRONIK INTRODUCES PULSAR-35 SELF-EXPANDING STENT AND PASSEO-14 PTA BALLOON CATHETER
TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
STENTYS LAUNCHES NEW STENT-DELIVERY SYSTEM TO ALLOW IMPLANTATION IN COMPLEX VESSEL ANATOMIES.
MALLINCKRODT SIGNS DEFINITIVE AGREEMENT TO ACQUIRE CNS THERAPEUTICS
BOSTON SCIENTIFIC OBTAINS BRIDGE-POINT MEDICAL TO BOLSTER INTERVENTIONAL CARDIOLOGY BUSINESS
SORIN GROUP ACQUIRES SFDA SANCTION AND DECLARES COMMERCIAL LAUNCH OF REPLYâ„¢ AND ESPRITâ„¢ FAMILIES OF PACEMAKERS IN CHINA
FDA SANCTIONS REMOTE CARDIAC ARRHYTHMIA MONITOR
VIRTUOSAPH® PLUS ENDOSCOPIC VESSEL HARVESTING SYSTEM FROM TERUMO OFFERS CARDIAC SURGERY TEAM WITH CONTROL, CONSISTENCY AND CONFIDENCE
ENDOLOGIX ACHIEVES CE MARK FOR NELLIX(R) ENDOVASCULAR ANEURYSM SEALING SYSTEM
BOSON BIOTECH COMPLETES CE REGISTRATION OF OVER FORTY PRODUCTS.
POSITRON and JUBILANT DRAXIMAGE APPROVES FOR A STRATEGIC COLLABORATION FOR SR-82/RB-82 GENERATORS.
MILLAR INSTRUMENTS COMPLETES MERGER WITH TELEMETRY RESEARCH.
STEMI ALERT SMARTPHONE APP - A LIFESAVER.
ABBOTT OBTAINS FDA APPROVAL FOR OMNILINK ELITE® VASCULAR BALLOON-EXPANDABLE STENT SYSTEM FOR TREATMENT OF ILIAC ARTERY DISEASE
BIOTRONIK LUMAX 740 DEFIBRILLATOR IMPLANTED ON U.S. PATIENT
STUDY PUBLISHED IN JAMA CORROBORATES BIOMATRIX â„¢ REDUCES CARDIAC ACTIONS IN ACUTE MI PATIENTS WITH GREATER EFFICIENCY THAN A BARE-METAL STENT
MORTARA INSTRUMENT, INC. ANNOUNCES FDA CLEARANCE OF RSCRIBE 5 ELECTROCARDIOGRAPH SYSTEM WITHIN THE U.S.
FRESENIUS KABI PROCURES FENWAL HOLDINGS, INC.
SORIN GROUP DECLARES THE ACQUISITION OF CALIFORNIA MEDICAL LABORATORIES
EDWARDS INTUITY VALVE SYSTEM RECEIVES IDE FROM FDA TO BEGIN TRANSFORM TRIAL IN U.S.
SORIN GROUP ACQUIRES CALIFORNIA MEDICAL LABORATORIES (CALMED) FOR $14 MILLION.
SIEMENS LAUNCHES ACUSON P300 COMPACT PORTABLE ULTRASOUND SYSTEM.
THORATEC INTRODUCES THORATEC CONNECTâ„¢, THE FIRST CLOUD-BASED ADVANCED MCS PROGRAM MANAGEMENT SYSTEM
COVIDIEN ACQUIRES ORIDION SYSTEMS
DSM ACQUIRES KENSEY NASH.
BAYER INTRODUCES MEDRAD MARK 7 ARTERION® INJECTION SYSTEM.
SORIN GROUP AND ORANGE BUSINESS SERVICES INTRODUCE A REMOTE MONITORING SOLUTION FOR PATIENTS WITH IMPLANTED CARDIAC DEVICES IN EUROPE
SORIN GROUP AND ORANGE BUSINESS SERVICES LAUNCH REMOTE MONITORING SOLUTION FOR PATIENTS WITH IMPLANTED CARDIAC DEVICES IN EUROPE.
ENDOSENSE AND BIOTRONIK ANNOUNCE CE MARK APPROVAL FOR ENDOSENSE'S TACTICATH® QUARTZ FORCE-SENSING ABLATION CATHETER
IDEV TECHNOLOGIES INTRODUCES SUREPATHâ„¢ GUIDEWIRES
AORTECH POLYMERS HAVE A PIVOTAL ROLE IN MAQUET/AVALON LABS CONTRACT
IDEV TECHNOLOGIES COMPLETES ENROLLMENT OF SUPERB CLINICAL TRIAL
AORTECH INTRODUCES ISO CERTIFICATION
BIOSENSE WEBSTER LAUNCHES THERMOCOOL® SF NAV CATHETER WITH CURVE VISUALIZATION
VYGON TO FOCUS ON NEEDLE-FREE VASCULAR ACCESS STANDARDS AT THE WOCOVA 2012
FCC RULE FOR WIRELESS MEDICAL SENSOR TECHNOLOGIES
COOK MEDICAL LAUNCHES ZILVER® PTX® DRUG-ELUTING PERIPHERAL STENT IN AUSTRALIA
K-TUBE TECHNOLOGIES LAUNCHES NEW RESEARCH AND DEVELOPMENT PROCESS K-TUBE DISCOVER
MINDRAY MEDICAL RENEWS AGREEMENT WITH HEALTHTRUST PURCHASING GROUP, L.P. TO PROVIDE PATIENT MONITORING EQUIPMENT.
CRYOLIFE ACQUIRES HEMOSPHERE
COVIDIEN ACQUIRES SUPERDIMENSION, LTD.
BIOTRONIK UNVEILS REOCOR EXTERNAL PACEMAKER TO ITS EXTERNAL PRODUCT PORTFOLIO
FDA APPROVES BIOTRONIK'S NEXT GENERATION ICDS AND CRT-DS
PHILIPS LAUNCHES WIRELESS ARRHYTHMIA MONITORING SERVICE.
HEARTBEAT INTERNATIONAL AND BIOTRONIK ALLIANCE AGAINST CARDIOVASCULAR DISEASE IN MEXICO
SORIN GROUP DECLARES FDA SANCTION AND MARKET INTRODUCTION OF PARADYMâ„¢ RF ICDS AND CRT-D IMPLANTABLE HEART DEVICES

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Personal mobility devices such as wheelchairs, mobility scooters, and stair lifts have witnessed significant growth in revenue and volume in the past few years. A personal mobility device is either a manual ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.